AXIM BIOTECHNOLOGIES, INC. — All Filings
306 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
144
15-12G
3
4
4/A
424B5
5
5/A
8-K
8-K/A
CORRESP
D
DEF 14C
EFFECT
NT 10-K
NT 10-Q
PRE 14C
PRER14C
S-1
S-1/A
S-3
S-8
SC 13D
SC 13D/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 15-12G | AXIM BIOTECHNOLOGIES, INC. FORM 15-12G | 0001096906-24-002227 | Dec 6, 2024 | — |
| NT 10-Q | AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q | 0001096906-24-002103 | Nov 13, 2024 | Sep 30, 2024 |
| 4 | PRIMARY DOCUMENT | 0001096906-24-002004 | Oct 15, 2024 | Jan 30, 2024 |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 0001096906-24-002002 | Oct 15, 2024 | Oct 9, 2024 |
| 10-Q | FORM 10-Q | 0001096906-24-001772 | Aug 19, 2024 | Jun 30, 2024 |
| NT 10-Q | AXIM BIOTECHNOLOGIES FORM 12B-25 | 0001096906-24-001686 | Aug 13, 2024 | Jun 30, 2024 |
| 10-Q/A | FORM 10-Q/A | 0001096906-24-001225 | May 22, 2024 | Mar 31, 2024 |
| 10-Q | FORM 10-Q | 0001096906-24-001202 | May 20, 2024 | Mar 31, 2024 |
| NT 10-Q | AXIM BIOTECHNOLOGIES FORM 12B-25 | 0001096906-24-001124 | May 15, 2024 | Mar 31, 2024 |
| 10-K | FORM 10-K | 0001096906-24-000864 | Apr 16, 2024 | Dec 31, 2023 |
| NT 10-K | AXIM BIOTECHNOLOGIES, INC. - NT 10K | 0001096906-24-000689 | Apr 1, 2024 | Dec 31, 2023 |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 0001096906-24-000539 | Mar 21, 2024 | Mar 15, 2024 |
| 4/A | PRIMARY DOCUMENT | 0001096906-24-000525 | Mar 19, 2024 | Mar 15, 2024 |
| 4 | PRIMARY DOCUMENT | 0001096906-24-000524 | Mar 19, 2024 | Mar 15, 2024 |
| 4 | PRIMARY DOCUMENT | 0001096906-24-000522 | Mar 19, 2024 | Mar 15, 2024 |
| 4 | PRIMARY DOCUMENT | 0001096906-24-000520 | Mar 19, 2024 | Mar 15, 2024 |
| 4 | PRIMARY DOCUMENT | 0001096906-24-000517 | Mar 19, 2024 | Mar 15, 2024 |
| 4 | PRIMARY DOCUMENT | 0001096906-24-000515 | Mar 19, 2024 | Mar 15, 2024 |
| 4 | PRIMARY DOCUMENT | 0001096906-24-000511 | Mar 19, 2024 | Mar 15, 2024 |
| 4 | PRIMARY DOCUMENT | 0001096906-24-000509 | Mar 19, 2024 | Mar 15, 2024 |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 0001096906-24-000199 | Feb 13, 2024 | Feb 7, 2024 |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 0001096906-23-002456 | Dec 28, 2023 | Dec 26, 2023 |
| 10-Q | FORM 10-Q | 0001096906-23-002238 | Nov 20, 2023 | Sep 30, 2023 |
| NT 10-Q | AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q | 0001096906-23-002168 | Nov 14, 2023 | Sep 30, 2023 |
| DEF 14C | AXIM BIOTECHNOLOGIES, INC. - DEF14C | 0001096906-23-001823 | Sep 21, 2023 | — |
| PRE 14C | SCHEDULE 14C INFORMATION | 0001096906-23-001726 | Aug 31, 2023 | Aug 30, 2023 |
| 10-Q | AXIM BIOTECHNOLOGIES FORM 10-Q | 0001096906-23-001655 | Aug 21, 2023 | Jun 30, 2023 |
| NT 10-Q | AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q | 0001096906-23-001597 | Aug 14, 2023 | Jun 30, 2023 |
| EFFECT | — | 9999999995-23-001716 | Jun 9, 2023 | — |
| CORRESP | — | 0001096906-23-001273 | Jun 7, 2023 | — |
| UPLOAD | — | 0000000000-23-006052 | Jun 7, 2023 | — |
| S-1 | FORM S-1 | 0001096906-23-001240 | Jun 2, 2023 | — |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 0001096906-23-001228 | Jun 2, 2023 | Jun 1, 2023 |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 0001096906-23-001206 | May 30, 2023 | May 23, 2023 |
| 3 | PRIMARY DOCUMENT | 0001096906-23-001204 | May 30, 2023 | May 23, 2023 |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 0001096906-23-001188 | May 25, 2023 | May 23, 2023 |
| 10-Q | FORM 10-Q | 0001096906-23-001168 | May 22, 2023 | Mar 31, 2023 |
| NT 10-Q | AXIM BIOTECHNOLOGIES, INC._FORM NT 10-Q | 0001096906-23-001077 | May 15, 2023 | Mar 31, 2023 |
| 10-K | FORM 10-K | 0001096906-23-000858 | Apr 17, 2023 | Dec 31, 2022 |
| NT 10-K | AXIM BIOTECHNOLOGIES, INC. - NT 10K | 0001096906-23-000686 | Mar 31, 2023 | Dec 31, 2022 |
| 8-K | AXIM BIOTECHNOLOGIES, INC. - FORM 8-K SEC FILING | 0001096906-23-000219 | Jan 27, 2023 | Jan 23, 2023 |
| 10-Q/A | FORM 10-Q/A | 0001096906-22-002783 | Nov 15, 2022 | Sep 30, 2022 |
| 10-Q | FORM 10-Q | 0001096906-22-002767 | Nov 14, 2022 | Sep 30, 2022 |
| 144 | — | 0000107476-22-000007 | Oct 7, 2022 | — |
| 4 | PRIMARY DOCUMENT | 0001096906-22-002340 | Sep 23, 2022 | — |
| 3 | PRIMARY DOCUMENT | 0001096906-22-002338 | Sep 23, 2022 | — |
| 4 | PRIMARY DOCUMENT | 0001096906-22-002337 | Sep 23, 2022 | — |
| 4 | PRIMARY DOCUMENT | 0001096906-22-002336 | Sep 23, 2022 | Dec 10, 2020 |
| 4 | PRIMARY DOCUMENT | 0001096906-22-002335 | Sep 23, 2022 | — |
| 4 | PRIMARY DOCUMENT | 0001096906-22-002334 | Sep 23, 2022 | May 13, 2020 |